These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22277292)

  • 1. [Referral criteria for benign prostatic hyperplasia in primary care: the 2011 update. Comité Científico de Criterios de Derivación en Hiperplasia Benigna de Próstata].
    Cózar JM; Castiñeiras J;
    Actas Urol Esp; 2012 Mar; 36(3):203-4. PubMed ID: 22277292
    [No Abstract]   [Full Text] [Related]  

  • 2. [Consensus document on the management and follow-up of the male with lower urinary tract symptoms secondary to benign prostate hyperplasia].
    Brenes Bermúdez FJ; Brotons Muntó F; Castiñeiras Fernández J; Cozar Olmo JM; Fernández-Pro Ledesma A; Martín Jiménez JA; Martínez-Berganza Asensio ML; Miñana López B; Molero García JM
    Semergen; 2016; 42(8):547-556. PubMed ID: 28314432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and erectile dysfunction in patients with benign prostatic hyperplasia.
    Montiel-Jarquín ÁJ; Gutiérrez-Quiroz CT; Pérez-Vázquez AL; Ortiz-Agustín JJ; García-Galicia A; Loría-Castellanos J
    Cir Cir; 2021; 89(2):218-222. PubMed ID: 33784271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benign prostatic hyperplasia management during COVID-19 pandemia.].
    Medina-Polo J; Téigell Tobar J; Romero-Otero J; Carballido-Rodríguez J; Domínguez-Esteban M; Martínez-Berganza ML; Miñana-López B; Unda Urzaiz JM; Rodríguez-Antolín A
    Arch Esp Urol; 2020 Jun; 73(5):405-412. PubMed ID: 32538810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Referral criteria for benign prostatic hyperplasia in primary care.Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina General, Sociedad Española de Medicina de Familia y Comunitaria, Asociación Española de Urología].
    Castiñeiras Fernández J; Cozar Olmo JM; Fernández-Pro A; Martín JA; Brenes Bermúdez FJ; Naval Pulido E; Molero JM; Pérez Morales D; ; ; ;
    Actas Urol Esp; 2010 Jan; 34(1):24-34. PubMed ID: 20223130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign prostatic hyperplasia referral criteria for primary care, 2011 version].
    Molero García JM; Pérez Morales D; Brenes Bermúdez F; Naval Pulido E; Fernández-Pro Pedraza A; Martín Jiménez JA; Castiñeiras Fernández J; Cozar Olmo JM
    Aten Primaria; 2012 Jun; 44(6):371-3. PubMed ID: 22019068
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of primary care referrals to urology. Impact of a protocol on prostate disease and continuing education.
    Sopeña-Sutil R; Tejido-Sánchez A; Galván-Ortiz de Urbina M; Guerrero-Ramos F; García-Álvarez G; Passas-Martínez JB
    Actas Urol Esp; 2015 Jun; 39(5):296-302. PubMed ID: 25554605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urology clinics referral Patterns after initiation of a Primary Care BPH-LUTS protocol.].
    Martínez Ruiz J; Carrión López P; Giménez Bachs JM; Pastor Navarro H; Martínez Sanchiz C; Fernández Anguita PJ; Moreillo Vicente L; Salinas Sánchez AS
    Arch Esp Urol; 2020 Sep; 73(7):573-581. PubMed ID: 32886072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Referral criteria for benign prostatic hyperplasia in primary care].
    Molero JM; Pérez Morales D; Brenes Bermúdez FJ; Naval Pulido E; Fernández-Pro A; Martín JA; Castiñeiras Fernández J; Cozar Olmo JM
    Aten Primaria; 2010 Jan; 42(1):36-46. PubMed ID: 19913947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)].
    Cambronero J; Osca-García JM; Merino-Salas S; Miguel JM; Borralleras C; López-Alcina E
    Arch Esp Urol; 2022 Apr; 75(3):219-227. PubMed ID: 35435166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha1-adrenogenic blockers and intraoperative floppy iris syndrome].
    Delgado Gallego S; Pérez Molto FJ; Cuadrado Escamilla JL; Soriano Lafarge A
    Aten Primaria; 2012 Jan; 44(1):51-2. PubMed ID: 21397359
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostatic artery embolization treatment for patients with benign prostatic hyperplasia who are permanent urinary catheter users ineligible for de-obstructive surgery.
    Salvador Hidalgo D; Bernardello Ureta M; Sbriglio M; García Gámez A; Sampere Moragas J; Areal Calama J; Ágreda Castañeda F
    Actas Urol Esp (Engl Ed); 2021 Sep; 45(7):481-485. PubMed ID: 34326030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Appropriateness of referral to urologists': can it be defined for symptoms of benign prostatic obstruction and used as a quality measure?
    Elwyn G; Jones S; Edwards P
    BJU Int; 1999 Feb; 83(3):238-42. PubMed ID: 10233486
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis at 2 years of surgical treatment of benign prostatic hyperplasia by photoselective vaporization of the prostate with GreenLight-Photo vaporization 120 W versus transurethral resection of the prostate.
    Benejam-Gual JM; Sanz-Granda A; García-Miralles Grávalos R; Severa-Ruíz de Velasco A; Pons-Viver J
    Actas Urol Esp; 2014 May; 38(4):238-43. PubMed ID: 24300307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia: an approach for the internist.
    Zippe CD
    Cleve Clin J Med; 1996; 63(4):226-36. PubMed ID: 8764693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology and diagnosis of benign prostata hyperplasia].
    Schlenker B; Seitz M; Reich O; Stief CG; Gratzke C
    MMW Fortschr Med; 2009 Oct; 151(41):31-2. PubMed ID: 19891181
    [No Abstract]   [Full Text] [Related]  

  • 17. Benign prostatic hyperplasia. A review of diagnostic and treatment options.
    Pfeiffer GM; Giacomarra M
    Adv Nurse Pract; 1999 Apr; 7(4):31-6; quiz 37-8. PubMed ID: 10382383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of quality of life in patients with benign prostatic hyperplasia under treatment with silodosin.
    Castro-Díaz D; Callejo D; Cortés X; Pérez M
    Actas Urol Esp; 2014; 38(6):361-6. PubMed ID: 24274903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signs of improvement: diabetes update 2009.
    Hill AN; Roche C; Appel SJ
    Nurse Pract; 2009 Jun; 34(6):12-22, quiz 23. PubMed ID: 19474626
    [No Abstract]   [Full Text] [Related]  

  • 20. Thulium laser enucleation (ThuLEP) versus transurethral resection of the prostate in saline (TURis): A randomized prospective trial to compare intra and early postoperative outcomes.
    Bozzini G; Seveso M; Melegari S; de Francesco O; Buffi NM; Guazzoni G; Provenzano M; Mandressi A; Taverna G
    Actas Urol Esp; 2017 Jun; 41(5):309-315. PubMed ID: 28062085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.